Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
Clinical trial NCT07160608 · RECRUITING
Trial details
- NCT number
- NCT07160608
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-26
- Primary completion
- 2027-10-11
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.